179 related articles for article (PubMed ID: 10588978)
1. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.
Brindley A
J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978
[TBL] [Abstract][Full Text] [Related]
2. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
Richards J; Hirst P; Pitcairn G; Mahashabde S; Abramowitz W; Nolting A; Newman SP
J Aerosol Med; 2001; 14(2):197-208. PubMed ID: 11681651
[TBL] [Abstract][Full Text] [Related]
3. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
[TBL] [Abstract][Full Text] [Related]
4. Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence.
Singh D; Tutuncu A; Lohr I; Carlholm M; Polanowski T
Int J Clin Pharmacol Ther; 2007 Sep; 45(9):485-95. PubMed ID: 17907591
[TBL] [Abstract][Full Text] [Related]
5. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
[TBL] [Abstract][Full Text] [Related]
6. Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition-valve performance.
Cummings RH
J Allergy Clin Immunol; 1999 Dec; 104(6):S230-6. PubMed ID: 10588980
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
Cripps A; Riebe M; Schulze M; Woodhouse R
Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
[TBL] [Abstract][Full Text] [Related]
8. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
Williams RO; Repka M; Liu J
Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
[TBL] [Abstract][Full Text] [Related]
10. Hydrofluoroalkane mandate in effect January 1, 2009: Switch from chlorofluorocarbon- to hydrofluoroalkane-propelled inhalers requires active transition.
Peters S
Clin Cornerstone; 2009; 9(3):50-3. PubMed ID: 19781516
[TBL] [Abstract][Full Text] [Related]
11. Moving from CFC aerosol to HFA aerosol or dry powder inhalers: what do patients think?
Hartung TK; Allbutt H; Dewar M; Innes JA; Crompton GK
Respiration; 2002; 69(4):314-9. PubMed ID: 12169743
[TBL] [Abstract][Full Text] [Related]
12. New delivery systems and propellants.
Dolovich M
Can Respir J; 1999; 6(3):290-5. PubMed ID: 10393290
[TBL] [Abstract][Full Text] [Related]
13. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[TBL] [Abstract][Full Text] [Related]
14. Plume temperature emitted from metered dose inhalers.
Brambilla G; Church T; Lewis D; Meakin B
Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting the efficiency of aerosol therapy with pressurised metered-dose inhalers through plastic spacers.
Chuffart AA; Sennhauser FH; Wildhaber JH;
Swiss Med Wkly; 2001 Jan; 131(1-2):14-8. PubMed ID: 11205181
[TBL] [Abstract][Full Text] [Related]
16. The challenge of reformulation.
Smith IJ
J Aerosol Med; 1995; 8 Suppl 1():S19-27. PubMed ID: 10150491
[TBL] [Abstract][Full Text] [Related]
17. Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial.
Escribano A; Tutuncu A; Löhr I; Carlholm M; Polanowski T
Curr Med Res Opin; 2006 Jun; 22(6):1085-92. PubMed ID: 16846541
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide.
Clearie KL; Williamson PA; Meldrum K; Gillen M; Carlsson LG; Carlholm M; Ekelund J; Lipworth BJ
Br J Clin Pharmacol; 2011 Apr; 71(4):504-13. PubMed ID: 21395643
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
